Chronic Kidney Disease
Chronic kidney disease (CKD) is the gradual loss of kidney function over time. The kidneys filter waste and excess fluids from blood, which are then excreted in urine. When CKD reaches an advanced stage, dangerous levels of fluid, electrolytes, and wastes can build up in the body. CKD can progress to end-stage renal disease requiring dialysis or transplant.
Prevalence
CKD affects approximately 37 million Americans (about 15% of adults). Many are unaware they have it. About 800,000 Americans have end-stage renal disease.
Who It Affects
Major risk factors include diabetes (leading cause), high blood pressure (second leading cause), heart disease, family history, and older age. African Americans, Hispanics, and Native Americans have higher rates of CKD.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Blood Pressure Control
ACE inhibitors or ARBs to protect kidneys and slow progression.
Limitations: Slows but doesn't stop progression. Requires careful monitoring of potassium and kidney function.
Diabetes Management
Tight blood sugar control to slow kidney damage progression.
Limitations: Reduces risk but doesn't reverse existing damage.
SGLT2 Inhibitors
Newer medications shown to slow CKD progression significantly.
Limitations: Cannot be used with very low kidney function. Side effects include genital infections.
Dialysis
Filters blood when kidneys fail (hemodialysis or peritoneal dialysis).
Limitations: Life-sustaining but burdensome. Requires frequent treatments. Quality of life impact.
Kidney Transplant
Best treatment for end-stage kidney disease when appropriate.
Limitations: Limited donor kidneys. Requires lifelong immunosuppression. Not all patients are candidates.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for chronic kidney disease is an emerging area of research exploring whether biologics may help slow progression or support kidney function. The kidney's complex structure makes regeneration particularly challenging, and research is in early stages.
Potential Benefits Being Studied:
- Being studied for potential to modulate kidney inflammation
- May help reduce fibrosis (scarring) progression
- Research is in early stages for kidney applications
- Cannot regenerate nephrons (functional kidney units)
- Some animal studies showing potential
- Does not replace kidney-protective medications
Biologics Used:
Mesenchymal stem cells in early research
Exosomes being studied for anti-fibrotic effects
Frequently Asked Questions
Can stem cells regenerate kidney function?
Currently, no therapy can regenerate lost nephrons or reverse significant kidney damage. Research focuses on potentially slowing progression. CKD management centers on protecting remaining kidney function.
What can actually slow CKD progression?
Blood pressure control with ACE inhibitors or ARBs, diabetes management, and SGLT2 inhibitors have the best evidence for slowing progression. These should be the foundation of CKD treatment.
Is this an alternative to dialysis?
No. Regenerative therapies are not proven to restore kidney function enough to avoid dialysis when kidneys fail. They are being studied as potential ways to slow progression in earlier stages.
Ready to Explore Your Options?
Schedule a free consultation to discuss chronic kidney disease and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for chronic kidney disease are investigational with very limited evidence. CKD requires ongoing nephrology care. Proven treatments (blood pressure control, SGLT2 inhibitors) should be prioritized.